देश: आयरलैंड
भाषा: अंग्रेज़ी
स्रोत: HMA (Heads of Medicines Agencies)
thiamazole 5 mg
Le Vet B.V
QH03BB02
Coated tablet
thiamazole
Cats Non Food
2013-05-29
Issued: August 2013 AN: 00232/2012 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Thiafeline 5 mg Film-coated Tablets for Cats (AT, BE, CZ, DE, EE, EL, ES, FR, HU, IE, IS, IT, LT, LU, LV, PL, PT, RO, SE, SK, UK) Thiafeline vet 5 mg Film-coated Tablets for cats (FI) Thiafeline Vet (DK, NO) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: ACTIVE SUBSTANCE: Thiamazole 5 mg EXCIPIENT(S): Titanium dioxide (E171) 0.15 mg Sunset Yellow FCF (E110) 0.09 mg Quinoline Yellow WS (E104) 0.075 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet. Orange biconvex tablets 5.5 mm diameter. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the stabilisation of hyperthyroidism in cats prior to surgical thyroidectomy. For the long-term treatment of feline hyperthyroidism. 4.3 CONTRAINDICATIONS Do not use in cats suffering from systemic disease such as primary liver disease or diabetes mellitus. Do not use in cats showing signs of autoimmune disease. Do not use in animals with disorders of white blood cells, such as neutropenia and lymphopenia. Do not use in animals with platelet disorders and coagulopathies (particularly thrombocytopenia). Issued: August 2013 AN: 00232/2012 Page 2 of 6 Do not use in pregnant or lactating females. Refer to section 4.7. Do not use in cats with hypersensitivity to thiamazole or the excipient पूरा दस्तावेज़ पढ़ें